Heartflow, Inc. (HTFL): Cash & Equivalents
$44.78M
As of 2025-12-31
$34.36M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $44.78M | -12.8% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $51.37M | -58.2% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $122.77M | n/a | 2026-03-18, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | 2025-12-31 | $44.78M | -12.8% |
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $42.24M | +20.9% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $28.13M | +52.4% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $10.71M | -5.7% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $3.19M | +504.6% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $17.05M | +175.1% |
| Cerus Corp (CERS) | 2025-12-31 | $19.96M | -1.5% |
| Orthopediatrics Corp (KIDS) | 2025-12-31 | $19.56M | -55.4% |
| Lemaitre Vascular Inc (LMAT) | 2025-12-31 | $28.24M | +10.3% |
Compare HTFL, SIBN, STIM, TMCI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗